Chemoinformaics analysis of 6,6-DIMETHYL-2-(3-OXOBUTYL)BICYCLO[3.1.1]HEPTAN-3-ONE
| Molecular Weight | 208.301 | nRot | 3 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 10 |
| Exact Molecular Weight | 208.146 | nRing | 3 |
| Solubility: LogS | -2.498 | nHRing | 0 |
| Solubility: LogP | 1.914 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 36.6499 |
| nHD | 0 | BPOL | 21.8001 |
| QED | 0.714 |
| Synth | 4.342 |
| Natural Product Likeliness | 2.105 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.001 |
| HIA | 0.009 |
| CACO-2 | -4.609 |
| MDCK | 0.000023 |
| BBB | 0.899 |
| PPB | 0.575543 |
| VDSS | 0.624 |
| FU | 0.428433 |
| CYP1A2-inh | 0.046 |
| CYP1A2-sub | 0.617 |
| CYP2c19-inh | 0.08 |
| CYP2c19-sub | 0.907 |
| CYP2c9-inh | 0.125 |
| CYP2c9-sub | 0.886 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.35 |
| CL | 14.896 |
| T12 | 0.594 |
| hERG | 0.006 |
| Ames | 0.004 |
| ROA | 0.034 |
| SkinSen | 0.091 |
| Carcinogencity | 0.082 |
| EI | 0.875 |
| Respiratory | 0.044 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.731431 |